BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24408071)

  • 1. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
    Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Zajdel W; Godlewski J; Bartuś M; Zmudka K; Chrapusta A; Konstanty-Kalandyk J; Węgrzyn P; Sobotka PA
    Kardiol Pol; 2014; 72(5):425-31. PubMed ID: 24408071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K; Sadowski J; Kapelak B; Zajdel W; Godlewski J; Bartuś S; Bochenek M; Bartuś M; Żmudka K; Sobotka PA
    Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal artery sympathetic nerve radiofrequency denervation.
    Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Podolec J; Bartuś M; Dziewierz A; Bartuś S; Zajdel W; Lakkireddy D
    Kardiol Pol; 2017; 75(9):899-906. PubMed ID: 28541590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
    Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
    Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.
    Yalagudri S; Raju N; Das B; Daware A; Maiya S; Jothiraj K; Ravikishore AG
    Indian Heart J; 2015; 67(3):207-13. PubMed ID: 26138176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
    EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
    Fischell TA; Ebner A; Gallo S; Ikeno F; Minarsch L; Vega F; Haratani N; Ghazarossian VE
    JACC Cardiovasc Interv; 2016 Mar; 9(6):589-98. PubMed ID: 27013159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.